Antimicrobial Resistance Is One Of The Top 10 Global Public Health Threats1
Antimicrobial resistance (AMR) occurs when bacteria, fungi, viruses, and parasites mutate naturally over time and no longer respond to modern medicines. This means that standard antibiotic treatments become ineffective and infections persist, increasing the risk of severe consequences to the patient. If we do not address AMR now, we will lose the ability to safely perform routine procedures and surgeries.
You Can Make A Difference In The Fight Against AMR!
Meet Vanessa Carter
Watch patient advocate Vanessa Carter share her experience and see how antimicrobial resistance affects everyone.
Antimicrobial Stewardship Is The Best Solution To Combat AMR
Antimicrobial stewardship (AMS) is defined as coordinated interventions which seek to limit patient exposure to antibiotics. The goal of AMS initiatives is to ensure that the right antibiotic is given to the right patient at the right time, with the right dose and via the right route—causing the least harm to the patient. In realistic terms, it is a multidisciplinary approach that aims to ensure that patients benefit from the most effective antibiotic treatments, while limiting the side effects and costs of unnecessary treatments.
You can do more with Stewardship
- Detect, prevent, and control multi-drug resistant infections
- Minimize the risk of healthcare-associated infections (HAI)
- Optimize the use of antibiotics
- Monitor and track resistance trends
About Antimicrobial Stewardship
Antimicrobial Stewardship Initiatives Have Proven Medical And Economic Benefits
Initiating a mixed-intervention plan that evolves over time will enable your health system to optimize antibiotic use, increase efficiencies, and help slow the spread of AMR.
Download A Consolidated Review Of Real-World Scientific Evidence.
Collaboration Drives Stewardship Improvements
Diagnostic data has the power to bring together laboratory professionals, clinicians, and pharmacists to improve collaboration and set antimicrobial stewardship goals unique to their institution. Andrea Prinzi, PhD, MPH, SM (ASCP) clinical microbiologist and medical science liaison at bioMérieux, discusses the value of cross-department communication and provides her expertise on building teamwork into AMS committees.
Read Andrea Prinzi's Editorial
Diagnostics Are At The Heart Of Antimicrobial Stewardship
Luke Moore, PhD, an infectious disease physician and clinical microbiologist in London, describes how optimized diagnostics and data-driven solutions can benefit antimicrobial stewardship initiatives by:
- Improving speed to diagnosis in a cost-effective manner
- Informing infection prevention measures
- Monitoring and analyzing resistance patterns throughout institutions
- Supporting clinical decision making at both the patient and population level
bioMérieux’s Diagnostic Solutions Advance Antimicrobial Stewardship
High medical value diagnostics and data-driven solutions can be used to provide you faster, more optimized antibiotic therapy guidance, to help improve patient outcomes, and reduce costs.
Putting diagnostics at the heart of AMS helps you drive informed therapy decisions from antibiotic initiation to optimization and discontinuation. Comprehensive solutions exist today to slow the spread of AMR and accelerate your stewardship program success.
bioMérieux is dedicated to helping you as a healthcare professional access actionable results faster because time-to-diagnosis and therapeutic efficacy are critical.
Optimize My DiagnosticsLearn More
Be A Game Changer By Advancing Antimicrobial Stewardship
Product availability varies by country. Consult your bioMérieux sales representative.